nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—Etoposide—uterine cancer	0.122	1	CbGbCtD
Risedronate—FDPS—myometrium—uterine cancer	0.0149	0.0859	CbGeAlD
Risedronate—PTGS2—artery—uterine cancer	0.0118	0.0682	CbGeAlD
Risedronate—FDPS—uterine cervix—uterine cancer	0.0116	0.0668	CbGeAlD
Risedronate—FDPS—smooth muscle tissue—uterine cancer	0.0113	0.065	CbGeAlD
Risedronate—FDPS—decidua—uterine cancer	0.011	0.0637	CbGeAlD
Risedronate—FDPS—renal system—uterine cancer	0.0108	0.0625	CbGeAlD
Risedronate—FDPS—endometrium—uterine cancer	0.0105	0.0605	CbGeAlD
Risedronate—FDPS—mammalian vulva—uterine cancer	0.0101	0.0585	CbGeAlD
Risedronate—FDPS—uterus—uterine cancer	0.00966	0.0557	CbGeAlD
Risedronate—FDPS—female reproductive system—uterine cancer	0.00868	0.0501	CbGeAlD
Risedronate—FDPS—female gonad—uterine cancer	0.0079	0.0456	CbGeAlD
Risedronate—FDPS—vagina—uterine cancer	0.00785	0.0453	CbGeAlD
Risedronate—PTGS2—myometrium—uterine cancer	0.00571	0.0329	CbGeAlD
Risedronate—FDPS—lymph node—uterine cancer	0.00508	0.0293	CbGeAlD
Risedronate—PTGS2—epithelium—uterine cancer	0.00448	0.0258	CbGeAlD
Risedronate—PTGS2—uterine cervix—uterine cancer	0.00444	0.0256	CbGeAlD
Risedronate—PTGS2—smooth muscle tissue—uterine cancer	0.00432	0.0249	CbGeAlD
Risedronate—PTGS2—renal system—uterine cancer	0.00416	0.024	CbGeAlD
Risedronate—PTGS2—endometrium—uterine cancer	0.00402	0.0232	CbGeAlD
Risedronate—PTGS2—uterus—uterine cancer	0.0037	0.0214	CbGeAlD
Risedronate—PTGS2—female reproductive system—uterine cancer	0.00333	0.0192	CbGeAlD
Risedronate—PTGS2—female gonad—uterine cancer	0.00303	0.0175	CbGeAlD
Risedronate—PTGS2—vagina—uterine cancer	0.00301	0.0174	CbGeAlD
Risedronate—PTGS2—lymph node—uterine cancer	0.00195	0.0112	CbGeAlD
Risedronate—Oesophagitis—Epirubicin—uterine cancer	0.00106	0.0015	CcSEcCtD
Risedronate—Eructation—Doxorubicin—uterine cancer	0.00105	0.0015	CcSEcCtD
Risedronate—Ecchymosis—Epirubicin—uterine cancer	0.00105	0.00149	CcSEcCtD
Risedronate—Neoplasm—Epirubicin—uterine cancer	0.00105	0.00149	CcSEcCtD
Risedronate—Bladder pain—Epirubicin—uterine cancer	0.00105	0.00149	CcSEcCtD
Risedronate—Cystitis noninfective—Doxorubicin—uterine cancer	0.00105	0.00149	CcSEcCtD
Risedronate—Influenza like illness—Doxorubicin—uterine cancer	0.00104	0.00148	CcSEcCtD
Risedronate—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00147	CcSEcCtD
Risedronate—Cystitis—Doxorubicin—uterine cancer	0.00104	0.00147	CcSEcCtD
Risedronate—Asthenia—Progesterone—uterine cancer	0.00104	0.00147	CcSEcCtD
Risedronate—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00147	CcSEcCtD
Risedronate—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00147	CcSEcCtD
Risedronate—Colitis—Doxorubicin—uterine cancer	0.00103	0.00146	CcSEcCtD
Risedronate—Urinary tract disorder—Etoposide—uterine cancer	0.00103	0.00146	CcSEcCtD
Risedronate—Pruritus—Progesterone—uterine cancer	0.00102	0.00145	CcSEcCtD
Risedronate—Urethral disorder—Etoposide—uterine cancer	0.00102	0.00145	CcSEcCtD
Risedronate—Hypertonia—Epirubicin—uterine cancer	0.00102	0.00144	CcSEcCtD
Risedronate—Infection—Dactinomycin—uterine cancer	0.00101	0.00144	CcSEcCtD
Risedronate—Dry eye—Doxorubicin—uterine cancer	0.000992	0.00141	CcSEcCtD
Risedronate—Diarrhoea—Progesterone—uterine cancer	0.000988	0.0014	CcSEcCtD
Risedronate—Cramps of lower extremities—Doxorubicin—uterine cancer	0.000986	0.0014	CcSEcCtD
Risedronate—Oesophagitis—Doxorubicin—uterine cancer	0.000981	0.00139	CcSEcCtD
Risedronate—Eye disorder—Etoposide—uterine cancer	0.000972	0.00138	CcSEcCtD
Risedronate—Bladder pain—Doxorubicin—uterine cancer	0.000971	0.00138	CcSEcCtD
Risedronate—Ecchymosis—Doxorubicin—uterine cancer	0.000971	0.00138	CcSEcCtD
Risedronate—Neoplasm—Doxorubicin—uterine cancer	0.000971	0.00138	CcSEcCtD
Risedronate—Cardiac disorder—Etoposide—uterine cancer	0.000965	0.00137	CcSEcCtD
Risedronate—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000964	0.00137	CcSEcCtD
Risedronate—Dizziness—Progesterone—uterine cancer	0.000955	0.00135	CcSEcCtD
Risedronate—Angiopathy—Etoposide—uterine cancer	0.000943	0.00134	CcSEcCtD
Risedronate—Hypertonia—Doxorubicin—uterine cancer	0.000941	0.00134	CcSEcCtD
Risedronate—Immune system disorder—Etoposide—uterine cancer	0.000939	0.00133	CcSEcCtD
Risedronate—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000939	0.00133	CcSEcCtD
Risedronate—Mediastinal disorder—Etoposide—uterine cancer	0.000937	0.00133	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00093	0.00132	CcSEcCtD
Risedronate—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000926	0.00131	CcSEcCtD
Risedronate—Vomiting—Progesterone—uterine cancer	0.000918	0.0013	CcSEcCtD
Risedronate—Rash—Progesterone—uterine cancer	0.00091	0.00129	CcSEcCtD
Risedronate—Dermatitis—Progesterone—uterine cancer	0.000909	0.00129	CcSEcCtD
Risedronate—Headache—Progesterone—uterine cancer	0.000904	0.00128	CcSEcCtD
Risedronate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000895	0.00127	CcSEcCtD
Risedronate—Fatigue—Dactinomycin—uterine cancer	0.00088	0.00125	CcSEcCtD
Risedronate—Back pain—Etoposide—uterine cancer	0.000875	0.00124	CcSEcCtD
Risedronate—Pain—Dactinomycin—uterine cancer	0.000873	0.00124	CcSEcCtD
Risedronate—Muscle spasms—Etoposide—uterine cancer	0.00087	0.00123	CcSEcCtD
Risedronate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000865	0.00123	CcSEcCtD
Risedronate—Nausea—Progesterone—uterine cancer	0.000858	0.00122	CcSEcCtD
Risedronate—Pain in extremity—Epirubicin—uterine cancer	0.000842	0.0012	CcSEcCtD
Risedronate—Osteoarthritis—Epirubicin—uterine cancer	0.000842	0.0012	CcSEcCtD
Risedronate—Anaemia—Etoposide—uterine cancer	0.000836	0.00119	CcSEcCtD
Risedronate—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000834	0.00118	CcSEcCtD
Risedronate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000832	0.00118	CcSEcCtD
Risedronate—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000825	0.00117	CcSEcCtD
Risedronate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000824	0.00117	CcSEcCtD
Risedronate—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00082	0.00116	CcSEcCtD
Risedronate—Vertigo—Etoposide—uterine cancer	0.000813	0.00115	CcSEcCtD
Risedronate—Abdominal pain—Dactinomycin—uterine cancer	0.000807	0.00114	CcSEcCtD
Risedronate—Body temperature increased—Dactinomycin—uterine cancer	0.000807	0.00114	CcSEcCtD
Risedronate—Loss of consciousness—Etoposide—uterine cancer	0.000795	0.00113	CcSEcCtD
Risedronate—Cough—Etoposide—uterine cancer	0.00079	0.00112	CcSEcCtD
Risedronate—Hypertension—Etoposide—uterine cancer	0.000781	0.00111	CcSEcCtD
Risedronate—Pain in extremity—Doxorubicin—uterine cancer	0.000779	0.00111	CcSEcCtD
Risedronate—Osteoarthritis—Doxorubicin—uterine cancer	0.000779	0.00111	CcSEcCtD
Risedronate—Liver function test abnormal—Epirubicin—uterine cancer	0.000778	0.0011	CcSEcCtD
Risedronate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000777	0.0011	CcSEcCtD
Risedronate—Chest pain—Etoposide—uterine cancer	0.00077	0.00109	CcSEcCtD
Risedronate—Abdominal pain upper—Epirubicin—uterine cancer	0.000769	0.00109	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000765	0.00109	CcSEcCtD
Risedronate—Breast disorder—Epirubicin—uterine cancer	0.000761	0.00108	CcSEcCtD
Risedronate—Nasopharyngitis—Epirubicin—uterine cancer	0.000753	0.00107	CcSEcCtD
Risedronate—Hypersensitivity—Dactinomycin—uterine cancer	0.000752	0.00107	CcSEcCtD
Risedronate—Gastritis—Epirubicin—uterine cancer	0.000745	0.00106	CcSEcCtD
Risedronate—Muscular weakness—Epirubicin—uterine cancer	0.000743	0.00105	CcSEcCtD
Risedronate—Infection—Etoposide—uterine cancer	0.000734	0.00104	CcSEcCtD
Risedronate—Abdominal distension—Epirubicin—uterine cancer	0.000733	0.00104	CcSEcCtD
Risedronate—Asthenia—Dactinomycin—uterine cancer	0.000732	0.00104	CcSEcCtD
Risedronate—Asthma—Epirubicin—uterine cancer	0.000728	0.00103	CcSEcCtD
Risedronate—Influenza—Epirubicin—uterine cancer	0.000728	0.00103	CcSEcCtD
Risedronate—Liver function test abnormal—Doxorubicin—uterine cancer	0.00072	0.00102	CcSEcCtD
Risedronate—Skin disorder—Etoposide—uterine cancer	0.000717	0.00102	CcSEcCtD
Risedronate—Abdominal pain upper—Doxorubicin—uterine cancer	0.000712	0.00101	CcSEcCtD
Risedronate—Angina pectoris—Epirubicin—uterine cancer	0.000709	0.00101	CcSEcCtD
Risedronate—Breast disorder—Doxorubicin—uterine cancer	0.000704	0.000999	CcSEcCtD
Risedronate—Bronchitis—Epirubicin—uterine cancer	0.0007	0.000993	CcSEcCtD
Risedronate—Diarrhoea—Dactinomycin—uterine cancer	0.000698	0.000991	CcSEcCtD
Risedronate—Nasopharyngitis—Doxorubicin—uterine cancer	0.000697	0.000989	CcSEcCtD
Risedronate—Gastritis—Doxorubicin—uterine cancer	0.00069	0.000979	CcSEcCtD
Risedronate—Muscular weakness—Doxorubicin—uterine cancer	0.000687	0.000975	CcSEcCtD
Risedronate—Abdominal distension—Doxorubicin—uterine cancer	0.000678	0.000962	CcSEcCtD
Risedronate—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000677	0.00096	CcSEcCtD
Risedronate—Asthma—Doxorubicin—uterine cancer	0.000674	0.000956	CcSEcCtD
Risedronate—Influenza—Doxorubicin—uterine cancer	0.000674	0.000956	CcSEcCtD
Risedronate—Paraesthesia—Etoposide—uterine cancer	0.000663	0.000941	CcSEcCtD
Risedronate—Dyspnoea—Etoposide—uterine cancer	0.000658	0.000934	CcSEcCtD
Risedronate—Angina pectoris—Doxorubicin—uterine cancer	0.000656	0.000931	CcSEcCtD
Risedronate—Pneumonia—Epirubicin—uterine cancer	0.000653	0.000926	CcSEcCtD
Risedronate—Infestation NOS—Epirubicin—uterine cancer	0.000649	0.000921	CcSEcCtD
Risedronate—Infestation—Epirubicin—uterine cancer	0.000649	0.000921	CcSEcCtD
Risedronate—Vomiting—Dactinomycin—uterine cancer	0.000649	0.000921	CcSEcCtD
Risedronate—Bronchitis—Doxorubicin—uterine cancer	0.000648	0.000919	CcSEcCtD
Risedronate—Rash—Dactinomycin—uterine cancer	0.000643	0.000913	CcSEcCtD
Risedronate—Gastrointestinal disorder—Etoposide—uterine cancer	0.000638	0.000905	CcSEcCtD
Risedronate—Fatigue—Etoposide—uterine cancer	0.000637	0.000903	CcSEcCtD
Risedronate—Pain—Etoposide—uterine cancer	0.000632	0.000896	CcSEcCtD
Risedronate—Constipation—Etoposide—uterine cancer	0.000632	0.000896	CcSEcCtD
Risedronate—Conjunctivitis—Epirubicin—uterine cancer	0.000631	0.000895	CcSEcCtD
Risedronate—Urinary tract infection—Epirubicin—uterine cancer	0.000631	0.000895	CcSEcCtD
Risedronate—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000626	0.000888	CcSEcCtD
Risedronate—Hepatobiliary disease—Epirubicin—uterine cancer	0.000614	0.000871	CcSEcCtD
Risedronate—Sinusitis—Epirubicin—uterine cancer	0.000609	0.000864	CcSEcCtD
Risedronate—Nausea—Dactinomycin—uterine cancer	0.000606	0.00086	CcSEcCtD
Risedronate—Pneumonia—Doxorubicin—uterine cancer	0.000604	0.000857	CcSEcCtD
Risedronate—Gastrointestinal pain—Etoposide—uterine cancer	0.000604	0.000857	CcSEcCtD
Risedronate—Infestation—Doxorubicin—uterine cancer	0.000601	0.000852	CcSEcCtD
Risedronate—Infestation NOS—Doxorubicin—uterine cancer	0.000601	0.000852	CcSEcCtD
Risedronate—Urticaria—Etoposide—uterine cancer	0.000587	0.000832	CcSEcCtD
Risedronate—Haemoglobin—Epirubicin—uterine cancer	0.000586	0.000831	CcSEcCtD
Risedronate—Rhinitis—Epirubicin—uterine cancer	0.000584	0.000829	CcSEcCtD
Risedronate—Abdominal pain—Etoposide—uterine cancer	0.000584	0.000828	CcSEcCtD
Risedronate—Body temperature increased—Etoposide—uterine cancer	0.000584	0.000828	CcSEcCtD
Risedronate—Urinary tract infection—Doxorubicin—uterine cancer	0.000584	0.000828	CcSEcCtD
Risedronate—Conjunctivitis—Doxorubicin—uterine cancer	0.000584	0.000828	CcSEcCtD
Risedronate—Haemorrhage—Epirubicin—uterine cancer	0.000583	0.000827	CcSEcCtD
Risedronate—Pharyngitis—Epirubicin—uterine cancer	0.000578	0.000821	CcSEcCtD
Risedronate—Urinary tract disorder—Epirubicin—uterine cancer	0.000575	0.000817	CcSEcCtD
Risedronate—Oedema peripheral—Epirubicin—uterine cancer	0.000574	0.000814	CcSEcCtD
Risedronate—Connective tissue disorder—Epirubicin—uterine cancer	0.000573	0.000812	CcSEcCtD
Risedronate—Urethral disorder—Epirubicin—uterine cancer	0.000571	0.00081	CcSEcCtD
Risedronate—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000568	0.000806	CcSEcCtD
Risedronate—Sinusitis—Doxorubicin—uterine cancer	0.000563	0.0008	CcSEcCtD
Risedronate—Eye disorder—Epirubicin—uterine cancer	0.000545	0.000773	CcSEcCtD
Risedronate—Hypersensitivity—Etoposide—uterine cancer	0.000544	0.000772	CcSEcCtD
Risedronate—Tinnitus—Epirubicin—uterine cancer	0.000543	0.000771	CcSEcCtD
Risedronate—Haemoglobin—Doxorubicin—uterine cancer	0.000542	0.000769	CcSEcCtD
Risedronate—Cardiac disorder—Epirubicin—uterine cancer	0.000541	0.000767	CcSEcCtD
Risedronate—Rhinitis—Doxorubicin—uterine cancer	0.000541	0.000767	CcSEcCtD
Risedronate—Haemorrhage—Doxorubicin—uterine cancer	0.000539	0.000765	CcSEcCtD
Risedronate—Pharyngitis—Doxorubicin—uterine cancer	0.000535	0.000759	CcSEcCtD
Risedronate—Urinary tract disorder—Doxorubicin—uterine cancer	0.000532	0.000756	CcSEcCtD
Risedronate—Oedema peripheral—Doxorubicin—uterine cancer	0.000531	0.000754	CcSEcCtD
Risedronate—Asthenia—Etoposide—uterine cancer	0.00053	0.000752	CcSEcCtD
Risedronate—Connective tissue disorder—Doxorubicin—uterine cancer	0.00053	0.000752	CcSEcCtD
Risedronate—Angiopathy—Epirubicin—uterine cancer	0.000529	0.00075	CcSEcCtD
Risedronate—Urethral disorder—Doxorubicin—uterine cancer	0.000529	0.00075	CcSEcCtD
Risedronate—Immune system disorder—Epirubicin—uterine cancer	0.000526	0.000747	CcSEcCtD
Risedronate—Mediastinal disorder—Epirubicin—uterine cancer	0.000525	0.000745	CcSEcCtD
Risedronate—Pruritus—Etoposide—uterine cancer	0.000523	0.000741	CcSEcCtD
Risedronate—Arrhythmia—Epirubicin—uterine cancer	0.000521	0.000739	CcSEcCtD
Risedronate—Mental disorder—Epirubicin—uterine cancer	0.000511	0.000724	CcSEcCtD
Risedronate—Malnutrition—Epirubicin—uterine cancer	0.000507	0.00072	CcSEcCtD
Risedronate—Diarrhoea—Etoposide—uterine cancer	0.000505	0.000717	CcSEcCtD
Risedronate—Eye disorder—Doxorubicin—uterine cancer	0.000504	0.000715	CcSEcCtD
Risedronate—Tinnitus—Doxorubicin—uterine cancer	0.000503	0.000713	CcSEcCtD
Risedronate—Cardiac disorder—Doxorubicin—uterine cancer	0.0005	0.00071	CcSEcCtD
Risedronate—Flatulence—Epirubicin—uterine cancer	0.0005	0.000709	CcSEcCtD
Risedronate—Back pain—Epirubicin—uterine cancer	0.000491	0.000696	CcSEcCtD
Risedronate—Angiopathy—Doxorubicin—uterine cancer	0.000489	0.000694	CcSEcCtD
Risedronate—Dizziness—Etoposide—uterine cancer	0.000488	0.000693	CcSEcCtD
Risedronate—Muscle spasms—Epirubicin—uterine cancer	0.000488	0.000692	CcSEcCtD
Risedronate—Immune system disorder—Doxorubicin—uterine cancer	0.000487	0.000691	CcSEcCtD
Risedronate—Mediastinal disorder—Doxorubicin—uterine cancer	0.000486	0.000689	CcSEcCtD
Risedronate—Arrhythmia—Doxorubicin—uterine cancer	0.000482	0.000683	CcSEcCtD
Risedronate—Mental disorder—Doxorubicin—uterine cancer	0.000472	0.00067	CcSEcCtD
Risedronate—Vomiting—Etoposide—uterine cancer	0.00047	0.000666	CcSEcCtD
Risedronate—Malnutrition—Doxorubicin—uterine cancer	0.000469	0.000666	CcSEcCtD
Risedronate—Anaemia—Epirubicin—uterine cancer	0.000469	0.000665	CcSEcCtD
Risedronate—Rash—Etoposide—uterine cancer	0.000466	0.000661	CcSEcCtD
Risedronate—Dermatitis—Etoposide—uterine cancer	0.000465	0.00066	CcSEcCtD
Risedronate—Headache—Etoposide—uterine cancer	0.000463	0.000656	CcSEcCtD
Risedronate—Flatulence—Doxorubicin—uterine cancer	0.000463	0.000656	CcSEcCtD
Risedronate—Vertigo—Epirubicin—uterine cancer	0.000456	0.000647	CcSEcCtD
Risedronate—Syncope—Epirubicin—uterine cancer	0.000455	0.000645	CcSEcCtD
Risedronate—Back pain—Doxorubicin—uterine cancer	0.000454	0.000644	CcSEcCtD
Risedronate—Muscle spasms—Doxorubicin—uterine cancer	0.000451	0.00064	CcSEcCtD
Risedronate—Loss of consciousness—Epirubicin—uterine cancer	0.000446	0.000633	CcSEcCtD
Risedronate—Cough—Epirubicin—uterine cancer	0.000443	0.000628	CcSEcCtD
Risedronate—Nausea—Etoposide—uterine cancer	0.000439	0.000622	CcSEcCtD
Risedronate—Hypertension—Epirubicin—uterine cancer	0.000438	0.000621	CcSEcCtD
Risedronate—Anaemia—Doxorubicin—uterine cancer	0.000434	0.000616	CcSEcCtD
Risedronate—Chest pain—Epirubicin—uterine cancer	0.000432	0.000613	CcSEcCtD
Risedronate—Arthralgia—Epirubicin—uterine cancer	0.000432	0.000613	CcSEcCtD
Risedronate—Myalgia—Epirubicin—uterine cancer	0.000432	0.000613	CcSEcCtD
Risedronate—Anxiety—Epirubicin—uterine cancer	0.00043	0.000611	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000429	0.000609	CcSEcCtD
Risedronate—Dry mouth—Epirubicin—uterine cancer	0.000422	0.000599	CcSEcCtD
Risedronate—Vertigo—Doxorubicin—uterine cancer	0.000422	0.000598	CcSEcCtD
Risedronate—Syncope—Doxorubicin—uterine cancer	0.000421	0.000597	CcSEcCtD
Risedronate—Loss of consciousness—Doxorubicin—uterine cancer	0.000413	0.000585	CcSEcCtD
Risedronate—Infection—Epirubicin—uterine cancer	0.000411	0.000584	CcSEcCtD
Risedronate—Cough—Doxorubicin—uterine cancer	0.00041	0.000581	CcSEcCtD
Risedronate—Shock—Epirubicin—uterine cancer	0.000407	0.000578	CcSEcCtD
Risedronate—Nervous system disorder—Epirubicin—uterine cancer	0.000406	0.000576	CcSEcCtD
Risedronate—Hypertension—Doxorubicin—uterine cancer	0.000405	0.000575	CcSEcCtD
Risedronate—Skin disorder—Epirubicin—uterine cancer	0.000402	0.000571	CcSEcCtD
Risedronate—Arthralgia—Doxorubicin—uterine cancer	0.0004	0.000567	CcSEcCtD
Risedronate—Chest pain—Doxorubicin—uterine cancer	0.0004	0.000567	CcSEcCtD
Risedronate—Myalgia—Doxorubicin—uterine cancer	0.0004	0.000567	CcSEcCtD
Risedronate—Anxiety—Doxorubicin—uterine cancer	0.000398	0.000565	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000397	0.000563	CcSEcCtD
Risedronate—Dry mouth—Doxorubicin—uterine cancer	0.000391	0.000554	CcSEcCtD
Risedronate—Infection—Doxorubicin—uterine cancer	0.000381	0.00054	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000377	0.000535	CcSEcCtD
Risedronate—Shock—Doxorubicin—uterine cancer	0.000377	0.000535	CcSEcCtD
Risedronate—Nervous system disorder—Doxorubicin—uterine cancer	0.000376	0.000533	CcSEcCtD
Risedronate—Insomnia—Epirubicin—uterine cancer	0.000374	0.000531	CcSEcCtD
Risedronate—Skin disorder—Doxorubicin—uterine cancer	0.000372	0.000528	CcSEcCtD
Risedronate—Paraesthesia—Epirubicin—uterine cancer	0.000372	0.000527	CcSEcCtD
Risedronate—Dyspnoea—Epirubicin—uterine cancer	0.000369	0.000524	CcSEcCtD
Risedronate—Dyspepsia—Epirubicin—uterine cancer	0.000364	0.000517	CcSEcCtD
Risedronate—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000357	0.000507	CcSEcCtD
Risedronate—Fatigue—Epirubicin—uterine cancer	0.000357	0.000506	CcSEcCtD
Risedronate—Constipation—Epirubicin—uterine cancer	0.000354	0.000502	CcSEcCtD
Risedronate—Pain—Epirubicin—uterine cancer	0.000354	0.000502	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000349	0.000495	CcSEcCtD
Risedronate—Insomnia—Doxorubicin—uterine cancer	0.000346	0.000492	CcSEcCtD
Risedronate—Paraesthesia—Doxorubicin—uterine cancer	0.000344	0.000488	CcSEcCtD
Risedronate—Dyspnoea—Doxorubicin—uterine cancer	0.000342	0.000485	CcSEcCtD
Risedronate—Gastrointestinal pain—Epirubicin—uterine cancer	0.000339	0.00048	CcSEcCtD
Risedronate—Dyspepsia—Doxorubicin—uterine cancer	0.000337	0.000478	CcSEcCtD
Risedronate—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000331	0.000469	CcSEcCtD
Risedronate—Fatigue—Doxorubicin—uterine cancer	0.00033	0.000469	CcSEcCtD
Risedronate—Urticaria—Epirubicin—uterine cancer	0.000329	0.000467	CcSEcCtD
Risedronate—Pain—Doxorubicin—uterine cancer	0.000328	0.000465	CcSEcCtD
Risedronate—Constipation—Doxorubicin—uterine cancer	0.000328	0.000465	CcSEcCtD
Risedronate—Body temperature increased—Epirubicin—uterine cancer	0.000327	0.000464	CcSEcCtD
Risedronate—Abdominal pain—Epirubicin—uterine cancer	0.000327	0.000464	CcSEcCtD
Risedronate—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000313	0.000444	CcSEcCtD
Risedronate—Hypersensitivity—Epirubicin—uterine cancer	0.000305	0.000433	CcSEcCtD
Risedronate—Urticaria—Doxorubicin—uterine cancer	0.000304	0.000432	CcSEcCtD
Risedronate—Body temperature increased—Doxorubicin—uterine cancer	0.000303	0.00043	CcSEcCtD
Risedronate—Abdominal pain—Doxorubicin—uterine cancer	0.000303	0.00043	CcSEcCtD
Risedronate—Asthenia—Epirubicin—uterine cancer	0.000297	0.000421	CcSEcCtD
Risedronate—Pruritus—Epirubicin—uterine cancer	0.000293	0.000416	CcSEcCtD
Risedronate—Diarrhoea—Epirubicin—uterine cancer	0.000283	0.000402	CcSEcCtD
Risedronate—Hypersensitivity—Doxorubicin—uterine cancer	0.000282	0.0004	CcSEcCtD
Risedronate—Asthenia—Doxorubicin—uterine cancer	0.000275	0.00039	CcSEcCtD
Risedronate—Dizziness—Epirubicin—uterine cancer	0.000274	0.000388	CcSEcCtD
Risedronate—Pruritus—Doxorubicin—uterine cancer	0.000271	0.000385	CcSEcCtD
Risedronate—Vomiting—Epirubicin—uterine cancer	0.000263	0.000373	CcSEcCtD
Risedronate—Diarrhoea—Doxorubicin—uterine cancer	0.000262	0.000372	CcSEcCtD
Risedronate—Rash—Epirubicin—uterine cancer	0.000261	0.00037	CcSEcCtD
Risedronate—Dermatitis—Epirubicin—uterine cancer	0.000261	0.00037	CcSEcCtD
Risedronate—Headache—Epirubicin—uterine cancer	0.000259	0.000368	CcSEcCtD
Risedronate—Dizziness—Doxorubicin—uterine cancer	0.000253	0.000359	CcSEcCtD
Risedronate—Nausea—Epirubicin—uterine cancer	0.000246	0.000349	CcSEcCtD
Risedronate—Vomiting—Doxorubicin—uterine cancer	0.000244	0.000346	CcSEcCtD
Risedronate—Rash—Doxorubicin—uterine cancer	0.000242	0.000343	CcSEcCtD
Risedronate—Dermatitis—Doxorubicin—uterine cancer	0.000241	0.000342	CcSEcCtD
Risedronate—Headache—Doxorubicin—uterine cancer	0.00024	0.00034	CcSEcCtD
Risedronate—Nausea—Doxorubicin—uterine cancer	0.000228	0.000323	CcSEcCtD
